High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas

Accumulating data indicates that enhancer of zeste homology 2 (EZH2) and isocitrate dehydrogenase 1 (IDH1) are implicated in promoting tumourigenesis in a myriad of malignancies including gliomas. We aimed to determine the immunoexpression of EZH2 in gliomas and its correlation with clinicopathologi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yin Ping Wong, Roziasyazni Che Abdul Aziz, Azimatun Noor Aizuddin, Muhamad Fakhri Mohd Saleh, Roslina Mohd Arshad, Geok Chin Tan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-09-01
Colecção:	Diagnostics
Assuntos:	EZH2 glioma IDH1 R132H immunohistochemistry overall survival prognosis
Acesso em linha:	https://www.mdpi.com/2075-4418/12/10/2383
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!